| Detected | Trial | Change |
|---|---|---|
| 2026-06-06 | NCT06868212 A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in… |
Trial sites expanded: 114 -> 128 locations |
| 2026-06-05 | NCT04287621 Registry of Asthma Patients Initiating DUPIXENT® |
Trial completed |
| 2026-06-05 | NCT06881251 A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic… |
Trial terminated |
| 2026-06-05 | NCT06881251 A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic… |
critical why stopped: null → "Terminated: futility criteria met at interim efficacy analysis." |
| 2026-05-23 | NCT06572228 Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-23 | NCT06572228 Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting… |
Enrollment reduced: 250 -> 120 participants |
| 2026-05-23 | NCT06572228 Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting… |
Trial sites reduced: 84 -> 77 locations |
| 2026-05-23 | NCT06572228 Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting… |
date change Primary completion pushed: 2026-12-31 -> 2027-04-24 |
| 2026-05-23 | NCT06572228 Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting… |
date change Completion pushed: 2026-12-31 -> 2027-04-24 |
| 2026-05-21 | NCT07053423 A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants… |
Trial sites expanded: 58 -> 61 locations |
| 2026-05-21 | NCT07053423 A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants… |
date change Completion moved earlier: 2029-04-04 -> 2029-02-02 |
| 2026-05-16 | NCT07502534 A Clinical Study Comparing the Bioequivalence of IBI3027 and DUPIXENT®(Dupilumab) in… |
overall status: "Not Yet Recruiting" → "Active Not Recruiting" |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-14 | NCT07587658 This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is… | Phase 4 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05042258 | Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With… | Atopic Dermatitis | Recruiting |
| NCT07053423 | A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants… | Chronic Obstructive Pulmonary Disease | Recruiting |
| NCT05858619 | Molecular Signatures of Cutaneous Dupilumab Response | Atopic Dermatitis | Recruiting |
| NCT03694158 | Investigating Dupilumab's Effect in Asthma by Genotype | Asthma | Active, Not Recruiting |
| NCT03935971 | The Effects of Dupilumab on Allergic Contact Dermatitis | Allergic Contact Dermatitis | Active, Not Recruiting |
| NCT05983068 | A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric… | Dermatitis Atopic | Active, Not Recruiting |
| NCT05097287 | Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline… | Asthma | Active, Not Recruiting |
| NCT06352073 | Dupilumab for Eosinophilic Esophagitis With Severe Strictures | Eosinophilic Esophagitis | Active, Not Recruiting |
| NCT07587658 | This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is… | Chronic Obstructive Pulmonary Disease (COPD) | Not Yet Recruiting |
| NCT06572228 | Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting… | Asthma | Active, Not Recruiting |
| NCT07352566 | Utilization of a Microdevice for Psoriasis and Atopic Dermatitis | Psoriasis | Not Yet Recruiting |
| Phase 3 | |||
| NCT06293053 | A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6… | Prurigo Nodularis | Recruiting |
| NCT06191315 | Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic… | Wheezing | Recruiting |
| NCT06461897 | A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral… | Atopic Dermatitis | Recruiting |
| NCT07112378 | A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food… | Eosinophilic Esophagitis (EoE) | Recruiting |
| NCT06389136 | A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis… | Atopic Dermatitis | Recruiting |
| NCT06868212 | A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in… | Chronic Spontaneous Urticaria (CSU) | Recruiting |
| NCT05263206 | Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants… | Pruritus | Recruiting |
| NCT06687967 | A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab… | Lichen Simplex Chronicus | Active, Not Recruiting |
| NCT06687980 | A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab… | Lichen Simplex Chronicus | Active, Not Recruiting |
| NCT07386743 | A Phase III Study of GS101 Injection to Dupixent® | Atopic Dermatitis (AD) | Not Yet Recruiting |
| NCT02612454 | Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months… | Atopic Dermatitis | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT05535738 | Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation | Skin Inflammation | Active, Not Recruiting |
| Phase 2 | |||
| NCT07399067 | A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis | Atopic Dermatitis | Recruiting |
| NCT05866562 | Dupilumab in the Treatment of Pediatric Alopecia Areata | Alopecia Areata | Recruiting |